Chapin Davis’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Sell
21,427
-153
-0.7% -$8.79K 0.22% 78
2026
Q1
$1.31M Buy
21,580
+1,107
+5% +$64.5K 0.29% 73
2025
Q4
$1.1M Sell
20,473
-9,192
-31% -$442K 0.26% 80
2025
Q3
$1.34M Buy
29,665
+1,227
+4% +$57.3K 0.33% 68
2025
Q2
$1.32M Sell
28,438
-1,276
-4% -$62.6K 0.36% 65
2025
Q1
$1.81M Buy
29,714
+5,977
+25% +$348K 0.62% 36
2024
Q4
$1.23M Hold
23,737
0.4% 62
2024
Q3
$1.23M Buy
23,737
+53
+0.2% +$2.49K 0.4% 63
2024
Q2
$984K Buy
23,684
+1,140
+5% +$51K 0.34% 69
2024
Q1
$1.22M Buy
22,544
+4,159
+23% +$212K 0.45% 51
2023
Q4
$943K Buy
18,385
+214
+1% +$11.2K 0.4% 63
2023
Q3
$1.05M Sell
18,171
-166
-0.9% -$10.2K 0.5% 51
2023
Q2
$1.17M Buy
18,337
+32
+0.2% +$2.15K 0.56% 46
2023
Q1
$1.27M Buy
18,305
+4,694
+34% +$331K 0.66% 35
2022
Q4
$979K Buy
+13,611
New +$1.03M 0.57% 47

Other funds holding BMY

Chapin Davis's BMY Position: Q2 2026 in Review

Chapin Davis reduced its Bristol-Myers Squibb (BMY) stake by 0.71% in Q2 2026, selling an estimated $8.79K and leaving 21,427 shares worth $1.23M. The position accounts for 0.22% of the portfolio, ranked #78.

Chapin Davis first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.81M in Q1 2025. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Chapin Davis held 21,427 shares of Bristol-Myers Squibb worth $1.23M as of Q2 2026.
  • Chapin Davis sold 153 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.79K.
  • Bristol-Myers Squibb made up 0.22% of Chapin Davis's portfolio in Q2 2026, its #78 holding.
  • Chapin Davis first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
  • Chapin Davis's Bristol-Myers Squibb position peaked at $1.81M in Q1 2025.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.